See more : Wealth Glory Holdings Limited (8269.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Fluicell AB (publ) (FLUI.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fluicell AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Telix Pharmaceuticals Limited (TLX.AX) Income Statement Analysis – Financial Results
- Elliptic Laboratories ASA (ELABS.OL) Income Statement Analysis – Financial Results
- Daou Data Corp. (032190.KQ) Income Statement Analysis – Financial Results
- Mac Hotels Limited (MACH.BO) Income Statement Analysis – Financial Results
- Solar Enertech Corp. (SOEN) Income Statement Analysis – Financial Results
Fluicell AB (publ) (FLUI.ST)
About Fluicell AB (publ)
Fluicell AB (publ) provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company offers BioPen PRIME and BioPen FLEX microfluidic systems for maintaining localized solution delivery in single-cell experiments, as well as enabling control of the chemical environment around single intact cells in tissue or cell cultures; and Dynaflow Resolve system, a secondary ion channel screening platform, which allows for recording of various ion channel current in patch-clamp recording configuration. The company was founded in 2012 and is based in Gothenburg, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.34M | 3.25M | 2.60M | 4.64M | 2.49M | 1.23M | 1.05M | 2.64M | 1.42M | 140.27K |
| Cost of Revenue | 1.60M | 663.00K | 715.00K | 988.00K | 443.00K | 391.00K | 8.49M | 7.59M | 5.26M | 53.05K |
| Gross Profit | 1.74M | 2.59M | 1.89M | 3.65M | 2.05M | 835.00K | -7.44M | -4.96M | -3.85M | 87.22K |
| Gross Profit Ratio | 52.07% | 79.61% | 72.52% | 78.68% | 82.19% | 68.11% | -707.41% | -188.16% | -271.86% | 62.18% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 9.94M | 7.13M | 8.32M | 7.43M | 3.96M | 4.65M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 27.39M | 9.94M | 7.13M | 8.32M | 7.43M | 3.96M | 4.65M | 2.36M | 1.75M |
| Other Expenses | 28.62M | 24.32M | 13.64M | 13.54M | 12.41M | 8.18M | 4.53M | 2.95M | 0.00 | 0.00 |
| Operating Expenses | 28.62M | 24.32M | 23.58M | 20.67M | 20.73M | 15.61M | 8.49M | 7.60M | 2.31M | 1.72M |
| Cost & Expenses | 30.22M | 24.98M | 24.30M | 21.66M | 21.17M | 16.00M | 8.49M | 7.60M | 5.26M | 1.78M |
| Interest Income | 879.00K | 358.00K | 29.00K | 564.00K | 48.00K | 80.00K | 0.00 | 43.00K | 38.69K | 10.07K |
| Interest Expense | 30.00K | 238.00K | 27.00K | 564.00K | 0.00 | 2.00K | 34.00K | 27.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 610.00K | 720.00K | 588.00K | 605.00K | 522.00K | 326.00K | 71.00K | 85.00K | 58.39K | 46.76K |
| EBITDA | -25.91M | -20.89M | -21.08M | -16.42M | -18.11M | -14.37M | -7.37M | -4.84M | -3.67M | -1.59M |
| EBITDA Ratio | -776.33% | -635.16% | -810.07% | -354.28% | -728.01% | -1,172.27% | -700.10% | -183.61% | -267.74% | -1,133.58% |
| Operating Income | -26.88M | -21.73M | -21.70M | -17.03M | -18.68M | -14.78M | -7.44M | -4.97M | -3.85M | -1.64M |
| Operating Income Ratio | -805.24% | -668.32% | -833.78% | -367.34% | -750.92% | -1,205.38% | -706.84% | -188.46% | -271.86% | -1,166.91% |
| Total Other Income/Expenses | 325.00K | 120.00K | 2.00K | -564.00K | 48.00K | 78.00K | -34.00K | 16.00K | 65.63K | -10.07K |
| Income Before Tax | -26.55M | -21.61M | -21.69M | -17.59M | -18.64M | -14.70M | -7.47M | -4.95M | -3.78M | -1.65M |
| Income Before Tax Ratio | -795.51% | -664.63% | -833.70% | -379.50% | -749.00% | -1,199.02% | -710.08% | -187.86% | -267.23% | -1,174.10% |
| Income Tax Expense | 0.00 | -120.00K | 27.00K | 564.00K | 398.14K | -78.00K | 34.00K | -16.00K | 2.00 | 0.00 |
| Net Income | -26.55M | -21.49M | -21.72M | -18.15M | -18.64M | -14.70M | -7.47M | -4.95M | -3.78M | -1.65M |
| Net Income Ratio | -795.51% | -660.94% | -834.74% | -391.67% | -749.00% | -1,199.02% | -710.08% | -187.86% | -267.23% | -1,174.10% |
| EPS | -0.24 | -0.32 | -0.37 | -0.33 | -0.52 | -1.76 | -1.10 | -0.73 | -1.16 | -0.50 |
| EPS Diluted | -0.24 | -0.32 | -0.37 | -0.33 | -0.52 | -1.76 | -1.10 | -0.73 | -1.06 | -0.46 |
| Weighted Avg Shares Out | 112.16M | 67.70M | 59.21M | 55.05M | 35.96M | 8.36M | 6.79M | 6.79M | 3.28M | 3.28M |
| Weighted Avg Shares Out (Dil) | 112.16M | 67.70M | 59.21M | 55.05M | 35.96M | 8.36M | 6.79M | 6.79M | 3.57M | 3.57M |
Source: https://incomestatements.info
Category: Stock Reports